 | • レポートコード：20QY06-02794 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、パクリタキセル注射のグローバル市場について種類別（薬物強度、原材料パクリタキセルAPIソース）、用途別（卵巣癌、乳癌、子宮頸癌、膵癌、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・パクリタキセル注射市場の概要 ・世界の主要地域別パクリタキセル注射市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のパクリタキセル注射市場規模2015-2026：種類別（薬物強度、原材料パクリタキセルAPIソース） ・世界のパクリタキセル注射市場規模2015-2026：用途別（卵巣癌、乳癌、子宮頸癌、膵癌、その他） ・パクリタキセル注射の北米市場規模2015-2020 ・パクリタキセル注射のヨーロッパ市場規模2015-2020 ・パクリタキセル注射の中国市場規模2015-2020 ・パクリタキセル注射の日本市場規模2015-2020 ・パクリタキセル注射の東南アジア市場規模2015-2020 ・パクリタキセル注射のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol-Myers Squibb、Celgene Corporation、Hospira、Biological E.、Taj Accura、Khandelwal Laboratories、Luye Pharma、Beijing Youcare、Beijing Union、Haiyao、Chuntch） ・パクリタキセル注射の製造コスト分析 ・販売チャネル、流通業者、顧客 ・パクリタキセル注射の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Paclitaxel Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Paclitaxel Injection market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi’s sarcoma, it may be given once every 2 or 3 weeks.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Paclitaxel Injection market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Paclitaxel Injection industry.
Based on our recent survey, we have several different scenarios about the Paclitaxel Injection YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2720.1 million in 2019. The market size of Paclitaxel Injection will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Paclitaxel Injection market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Paclitaxel Injection market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Paclitaxel Injection market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Paclitaxel Injection market. The report also includes nautical information, where it shows Paclitaxel Injection market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Paclitaxel Injection market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Paclitaxel Injection market.
In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.
In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.
In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What’s more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.
At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.
In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.
Geographical Analysis:
Based on region, the global Paclitaxel Injection market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Paclitaxel Injection market are
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
Segment by Type
Drug Strength
Raw meterial Paclitaxel API source
Segment by Application
Ovarian cancer
Breast cancer
Cervical cancer
Pancreatic cancer
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Paclitaxel Injection market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Paclitaxel Injection market.
• The market share of the global Paclitaxel Injection market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Paclitaxel Injection market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Paclitaxel Injection market.
1 Paclitaxel Injection Market Overview
1.1 Paclitaxel Injection Product Scope
1.2 Paclitaxel Injection Segment by Type
1.2.1 Global Paclitaxel Injection Sales by Type (2020-2026)
1.2.2 Drug Strength
1.2.3 Raw meterial Paclitaxel API source
1.3 Paclitaxel Injection Segment by Application
1.3.1 Global Paclitaxel Injection Sales Comparison by Application (2020-2026)
1.3.2 Ovarian cancer
1.3.3 Breast cancer
1.3.4 Cervical cancer
1.3.5 Pancreatic cancer
1.3.6 Other
1.4 Paclitaxel Injection Market Estimates and Forecasts (2015-2026)
1.4.1 Global Paclitaxel Injection Sales Growth Rate (2015-2026)
1.4.2 Global Paclitaxel Injection Revenue and Growth Rate (2015-2026)
1.4.3 Global Paclitaxel Injection Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Paclitaxel Injection Industry Impact
1.5.1 How the Covid-19 is Affecting the Paclitaxel Injection Industry
1.5.1.1 Paclitaxel Injection Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Paclitaxel Injection Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Paclitaxel Injection Players to Combat Covid-19 Impact
2 Paclitaxel Injection Estimate and Forecast by Region
2.1 Global Paclitaxel Injection Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Paclitaxel Injection Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Paclitaxel Injection Sales Market Share by Region (2015-2020)
2.2.2 Global Paclitaxel Injection Revenue Market Share by Region (2015-2020)
2.3 Global Paclitaxel Injection Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Paclitaxel Injection Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Paclitaxel Injection Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Paclitaxel Injection Estimates and Projections (2015-2026)
2.4.2 Europe Paclitaxel Injection Estimates and Projections (2015-2026)
2.4.3 China Paclitaxel Injection Estimates and Projections (2015-2026)
2.4.4 Japan Paclitaxel Injection Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Paclitaxel Injection Estimates and Projections (2015-2026)
2.4.6 India Paclitaxel Injection Estimates and Projections (2015-2026)
3 Global Paclitaxel Injection Competition Landscape by Players
3.1 Global Top Paclitaxel Injection Players by Sales (2015-2020)
3.2 Global Top Paclitaxel Injection Players by Revenue (2015-2020)
3.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel Injection as of 2019)
3.4 Global Paclitaxel Injection Average Price by Company (2015-2020)
3.5 Manufacturers Paclitaxel Injection Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Paclitaxel Injection Players (Opinion Leaders)
4 Global Paclitaxel Injection Market Size by Type
4.1 Global Paclitaxel Injection Historic Market Review by Type (2015-2020)
4.1.1 Global Paclitaxel Injection Sales Market Share by Type (2015-2020)
4.1.2 Global Paclitaxel Injection Revenue Market Share by Type (2015-2020)
4.1.3 Global Paclitaxel Injection Price by Type (2014-2020)
4.2 Global Paclitaxel Injection Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Paclitaxel Injection Sales Forecast by Type (2021-2026)
4.2.2 Global Paclitaxel Injection Revenue Forecast by Type (2021-2026)
4.2.3 Global Paclitaxel Injection Price Forecast by Type (2021-2026)
5 Global Paclitaxel Injection Market Size by Application
5.1 Global Paclitaxel Injection Historic Market Review by Application (2015-2020)
5.1.1 Global Paclitaxel Injection Sales Market Share by Application (2015-2020)
5.1.2 Global Paclitaxel Injection Revenue Market Share by Application (2015-2020)
5.1.3 Global Paclitaxel Injection Price by Application (2015-2020)
5.2 Global Paclitaxel Injection Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Paclitaxel Injection Sales Forecast by Application (2021-2026)
5.2.2 Global Paclitaxel Injection Revenue Forecast by Application (2021-2026)
5.2.3 Global Paclitaxel Injection Price Forecast by Application (2021-2026)
3 North America Paclitaxel Injection Market Facts & Figures
3.2 North America Paclitaxel Injection Sales Market Share by Company (2015-2020)
3.3 North America Paclitaxel Injection Sales Market Share by Type (2015-2020)
3.4 North America Paclitaxel Injection Sales Market Share by Application (2015-2020)
4 Europe Paclitaxel Injection Market Facts & Figures
4.2 Europe Paclitaxel Injection Sales Market Share by Company (2015-2020)
4.3 Europe Paclitaxel Injection Sales Market Share by Type (2015-2020)
4.4 Europe Paclitaxel Injection Sales Market Share by Application (2015-2020)
5 China Paclitaxel Injection Market Facts & Figures
5.2 China Paclitaxel Injection Sales Market Share by Company (2015-2020)
5.3 China Paclitaxel Injection Sales Market Share by Type (2015-2020)
5.4 China Paclitaxel Injection Sales Market Share by Application (2015-2020)
6 Japan Paclitaxel Injection Market Facts & Figures
6.2 Japan Paclitaxel Injection Sales Market Share by Company (2015-2020)
6.3 Japan Paclitaxel Injection Sales Market Share by Type (2015-2020)
6.4 Japan Paclitaxel Injection Sales Market Share by Application (2015-2020)
7 Southeast Asia Paclitaxel Injection Market Facts & Figures
7.2 Southeast Asia Paclitaxel Injection Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Paclitaxel Injection Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Paclitaxel Injection Sales Market Share by Application (2015-2020)
8 India Paclitaxel Injection Market Facts & Figures
8.2 India Paclitaxel Injection Sales Market Share by Company (2015-2020)
8.3 India Paclitaxel Injection Sales Market Share by Type (2015-2020)
8.4 India Paclitaxel Injection Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Paclitaxel Injection Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Paclitaxel Injection Corporation Information
12.1.2 Bristol-Myers Squibb Paclitaxel Injection Business Overview and Total Revenue
12.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Myers Squibb Paclitaxel Injection Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Celgene Corporation
12.2.1 Celgene Corporation Paclitaxel Injection Corporation Information
12.2.2 Celgene Corporation Paclitaxel Injection Business Overview and Total Revenue
12.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Celgene Corporation Paclitaxel Injection Products Offered
12.2.5 Celgene Corporation Recent Development
12.3 Hospira
12.3.1 Hospira Paclitaxel Injection Corporation Information
12.3.2 Hospira Paclitaxel Injection Business Overview and Total Revenue
12.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Hospira Paclitaxel Injection Products Offered
12.3.5 Hospira Recent Development
12.4 Biological E.
12.4.1 Biological E. Paclitaxel Injection Corporation Information
12.4.2 Biological E. Paclitaxel Injection Business Overview and Total Revenue
12.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biological E. Paclitaxel Injection Products Offered
12.4.5 Biological E. Recent Development
12.5 Taj Accura
12.5.1 Taj Accura Paclitaxel Injection Corporation Information
12.5.2 Taj Accura Paclitaxel Injection Business Overview and Total Revenue
12.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Taj Accura Paclitaxel Injection Products Offered
12.5.5 Taj Accura Recent Development
12.6 Khandelwal Laboratories
12.6.1 Khandelwal Laboratories Paclitaxel Injection Corporation Information
12.6.2 Khandelwal Laboratories Paclitaxel Injection Business Overview and Total Revenue
12.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Khandelwal Laboratories Paclitaxel Injection Products Offered
12.6.5 Khandelwal Laboratories Recent Development
12.7 Luye Pharma
12.7.1 Luye Pharma Paclitaxel Injection Corporation Information
12.7.2 Luye Pharma Paclitaxel Injection Business Overview and Total Revenue
12.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Luye Pharma Paclitaxel Injection Products Offered
12.7.5 Luye Pharma Recent Development
12.8 Beijing Youcare
12.8.1 Beijing Youcare Paclitaxel Injection Corporation Information
12.8.2 Beijing Youcare Paclitaxel Injection Business Overview and Total Revenue
12.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Beijing Youcare Paclitaxel Injection Products Offered
12.8.5 Beijing Youcare Recent Development
12.9 Beijing Union
12.9.1 Beijing Union Paclitaxel Injection Corporation Information
12.9.2 Beijing Union Paclitaxel Injection Business Overview and Total Revenue
12.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Beijing Union Paclitaxel Injection Products Offered
12.9.5 Beijing Union Recent Development
12.10 Haiyao
12.10.1 Haiyao Paclitaxel Injection Corporation Information
12.10.2 Haiyao Paclitaxel Injection Business Overview and Total Revenue
12.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Haiyao Paclitaxel Injection Products Offered
12.10.5 Haiyao Recent Development
12.11 Chuntch
12.11.1 Chuntch Paclitaxel Injection Corporation Information
12.11.2 Chuntch Paclitaxel Injection Business Overview and Total Revenue
12.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Chuntch Paclitaxel Injection Products Offered
12.11.5 Chuntch Recent Development
13 Paclitaxel Injection Manufacturing Cost Analysis
13.1 Paclitaxel Injection Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Paclitaxel Injection
13.4 Paclitaxel Injection Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Paclitaxel Injection Distributors List
14.3 Paclitaxel Injection Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Paclitaxel Injection Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Paclitaxel Injection Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Paclitaxel Injection Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Paclitaxel Injection Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Paclitaxel Injection Players to Combat Covid-19 Impact
Table 8. Global Market Paclitaxel Injection Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Paclitaxel Injection Sales (K Units) by Region (2015-2020)
Table 10. Global Paclitaxel Injection Sales Market Share by Region (2015-2020)
Table 11. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Paclitaxel Injection Revenue Share by Region (2015-2020)
Table 13. Global Paclitaxel Injection Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Paclitaxel Injection Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Paclitaxel Injection Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Paclitaxel Injection Revenue Share Forecast by Region (2021-2026)
Table 17. Global Paclitaxel Injection (K Units) of Key Companies (2015-2020)
Table 18. Global Paclitaxel Injection Sales Share by Company (2015-2020)
Table 19. Global Paclitaxel Injection Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Paclitaxel Injection Revenue Share by Company (2015-2020)
Table 21. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel Injection as of 2019)
Table 22. Global Paclitaxel Injection Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Paclitaxel Injection Manufacturing Sites and Area Served
Table 24. Manufacturers Paclitaxel Injection Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Paclitaxel Injection Players
Table 27. Global Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 28. Global Paclitaxel Injection Sales Share by Type (2015-2020)
Table 29. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Paclitaxel Injection Price (K Units) by Type (2015-2020)
Table 31. Global Paclitaxel Injection Sales Share by Type (2021-2026)
Table 32. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Paclitaxel Injection Revenue Share by Type (2021-2026)
Table 34. Global Paclitaxel Injection Price (K Units) by Type (2021-2026)
Table 35. Global Paclitaxel Injection Sales (K Units) by Application (2015-2020)
Table 36. Global Paclitaxel Injection Sales Share by Application (2015-2020)
Table 37. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Paclitaxel Injection Price (K Units) by Application (2015-2020)
Table 39. Global Paclitaxel Injection Sales (K Units) by Application (2021-2026)
Table 40. Global Paclitaxel Injection Sales Share by Application (2021-2026)
Table 41. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Paclitaxel Injection Revenue Share by Application (2021-2026)
Table 43. Global Paclitaxel Injection Price (K Units) by Application (2021-2026)
Table 44. United States Paclitaxel Injection Sales (K Units) by Company (2015-2020)
Table 45. United States Paclitaxel Injection Sales Market Share by Company (2015-2020)
Table 46. United States Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 47. United States Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 48. United States Paclitaxel Injection Sales (K Units) by Application (2015-2020)
Table 49. United States Paclitaxel Injection Sales Market Share by Application (2015-2020)
Table 50. Europe Paclitaxel Injection Sales (K Units) by Company (2015-2020)
Table 51. Europe Paclitaxel Injection Sales Market Share by Company (2015-2020)
Table 52. Europe Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 53. Europe Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 54. Europe Paclitaxel Injection Sales (K Units) by Application (2015-2020)
Table 55. Europe Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 56. China Paclitaxel Injection Sales (K Units) by Company (2015-2020)
Table 57. China Paclitaxel Injection Sales Market Share by Company (2015-2020)
Table 58. China Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 59. China Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 60. China Paclitaxel Injection Sales (K Units) by Application (2015-2020)
Table 61. China Paclitaxel Injection Sales Market Share by Application (2015-2020)
Table 62. Japan Paclitaxel Injection Sales (K Units) by Company (2015-2020)
Table 63. Japan Paclitaxel Injection Sales Market Share by Company (2015-2020)
Table 64. Japan Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 65. Japan Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 66. Japan Paclitaxel Injection Sales (K Units) by Application (2015-2020)
Table 67. Japan Paclitaxel Injection Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Paclitaxel Injection Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Paclitaxel Injection Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Paclitaxel Injection Sales Market Share by Application (2015-2020)
Table 74. India Paclitaxel Injection Sales (K Units) by Company (2015-2020)
Table 75. India Paclitaxel Injection Sales Market Share by Company (2015-2020)
Table 76. India Paclitaxel Injection Sales (K Units) by Type (2015-2020)
Table 77. India Paclitaxel Injection Sales Market Share by Type (2015-2020)
Table 78. India Paclitaxel Injection Sales (K Units) by Application (2015-2020)
Table 79. India Paclitaxel Injection Sales Market Share by Application (2015-2020)
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Paclitaxel Injection Product
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Celgene Corporation Corporation Information
Table 86. Celgene Corporation Description and Business Overview
Table 87. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Celgene Corporation Paclitaxel Injection Product
Table 89. Celgene Corporation Recent Development
Table 90. Hospira Corporation Information
Table 91. Hospira Description and Business Overview
Table 92. Hospira Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Hospira Paclitaxel Injection Product
Table 94. Hospira Recent Development
Table 95. Biological E. Corporation Information
Table 96. Biological E. Description and Business Overview
Table 97. Biological E. Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Biological E. Paclitaxel Injection Product
Table 99. Biological E. Recent Development
Table 100. Taj Accura Corporation Information
Table 101. Taj Accura Description and Business Overview
Table 102. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Taj Accura Paclitaxel Injection Product
Table 104. Taj Accura Recent Development
Table 105. Khandelwal Laboratories Corporation Information
Table 106. Khandelwal Laboratories Description and Business Overview
Table 107. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Khandelwal Laboratories Paclitaxel Injection Product
Table 109. Khandelwal Laboratories Recent Development
Table 110. Luye Pharma Corporation Information
Table 111. Luye Pharma Description and Business Overview
Table 112. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Luye Pharma Paclitaxel Injection Product
Table 114. Luye Pharma Recent Development
Table 115. Beijing Youcare Corporation Information
Table 116. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Beijing Youcare Description and Business Overview
Table 118. Beijing Youcare Paclitaxel Injection Product
Table 119. Beijing Youcare Recent Development
Table 120. Beijing Union Corporation Information
Table 121. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Beijing Union Description and Business Overview
Table 123. Beijing Union Paclitaxel Injection Product
Table 124. Beijing Union Recent Development
Table 125. Haiyao Corporation Information
Table 126. Haiyao Description and Business Overview
Table 127. Haiyao Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Haiyao Paclitaxel Injection Product
Table 129. Haiyao Recent Development
Table . Chuntch Corporation Information
Table . Chuntch Description and Business Overview
Table . Chuntch Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Chuntch Paclitaxel Injection Product
Table . Chuntch Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Paclitaxel Injection Distributors List
Table 138. Paclitaxel Injection Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Injection Product Picture
Figure 2. Global Paclitaxel Injection Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Paclitaxel Injection Market Share by Application in 2020 & 2026
Figure 6. Ovarian cancer Examples
Figure 7. Breast cancer Examples
Figure 8. Cervical cancer Examples
Figure 9. Pancreatic cancer Examples
Figure 10. Other Examples
Figure 11. Global Paclitaxel Injection Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Paclitaxel Injection Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Paclitaxel Injection Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Paclitaxel Injection Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Paclitaxel Injection Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Paclitaxel Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Paclitaxel Injection Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Paclitaxel Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Paclitaxel Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Paclitaxel Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Paclitaxel Injection Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Paclitaxel Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Paclitaxel Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Paclitaxel Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Paclitaxel Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Paclitaxel Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Paclitaxel Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Paclitaxel Injection Players Market Share by Revenue in Paclitaxel Injection 2015 & 2019
Figure 29. Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Paclitaxel Injection Revenue Share by Type (2015-2020)
Figure 31. Global Paclitaxel Injection Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Paclitaxel Injection Revenue Share by Application (2015-2020)
Figure 33. Global Paclitaxel Injection Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Paclitaxel Injection Sales Market Share by Type in 2019
Figure 35. United States Paclitaxel Injection Sales Market Share by Type in 2019
Figure 36. Europe Paclitaxel Injection Sales Market Share by Company in 2019
Figure 37. Europe Paclitaxel Injection Sales Market Share by Type in 2019
Figure 38. Europe Paclitaxel Injection Sales Market Share by Application in 2019
Figure 39. China Paclitaxel Injection Sales Market Share by Company in 2019
Figure 40. China Paclitaxel Injection Sales Market Share by Type in 2019
Figure 41. China Paclitaxel Injection Sales Market Share by Application in 2019
Figure 42. Japan Paclitaxel Injection Sales Market Share by Company in 2019
Figure 43. Japan Paclitaxel Injection Sales Market Share by Type in 2019
Figure 44. Japan Paclitaxel Injection Sales Market Share by Application in 2019
Figure 45. Southeast Asia Paclitaxel Injection Sales Market Share by Company in 2019
Figure 46. Southeast Asia Paclitaxel Injection Sales Market Share by Type in 2019
Figure 47. Southeast Asia Paclitaxel Injection Sales Market Share by Application in 2019
Figure 48. India Paclitaxel Injection Sales Market Share by Company in 2019
Figure 49. India Paclitaxel Injection Sales Market Share by Type in 2019
Figure 50. India Paclitaxel Injection Sales Market Share by Application in 2019
Figure 51. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Biological E. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Taj Accura Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Khandelwal Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Beijing Youcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Beijing Union Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Haiyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Chuntch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Paclitaxel Injection
Figure 64. Manufacturing Process Analysis of Paclitaxel Injection
Figure 65. Paclitaxel Injection Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
パクリタキセルの世界市場レポート2020 Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". In the l…- 注射用ミカファンギンナトリウムの世界市場レポート2020 Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 注射用マムシ由来凝血促進剤の世界市場レポート2020 Market Analysis and Insights: Global Haemocoagulase Agkistrodon for Injection Market The global Haemocoagulase Agkistrodon for Injection market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Haemocoagulase Agki…
- 腫瘍用注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oncology Injection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Injection Dr…
- カプロン酸ヒドロキシプロゲステロン注射の世界市場レポート2020 A recently published report by QY Research titled Global Hydroxyprogesterone Caproate Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistical…